Cargando…
The role of Interleukin 6 inhibitors in therapy of severe COVID-19
Cytokine storm syndrome (CSS) is a severe complication of inflammatory immune diseases or treatment of malignancies; it may also appear during the progression of COVID-19. CSS is caused by dysregulation of the synthesis of cytokines, including pro-inflammatory, regulatory, and anti-inflammatory cyto...
Autores principales: | Nasonov, E., Samsonov, M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by Elsevier Masson SAS.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7455113/ https://www.ncbi.nlm.nih.gov/pubmed/32920514 http://dx.doi.org/10.1016/j.biopha.2020.110698 |
Ejemplares similares
-
Olokizumab, a monoclonal antibody against interleukin-6, in combination with methotrexate in patients with rheumatoid arthritis inadequately controlled by tumour necrosis factor inhibitor therapy: efficacy and safety results of a randomised controlled phase III study
por: Feist, Eugen, et al.
Publicado: (2022) -
Coronavirus Infection 2019 (COVID-19) and Autoimmunity
por: Nasonov, E. L., et al.
Publicado: (2022) -
Role of Interleukin 6 Inhibitors in the Management of Rheumatoid Arthritis
por: Yip, Ronald Man Lung, et al.
Publicado: (2021) -
Interleukin-6 and severe COVID-19: a systematic review and meta-analysis
por: Mojtabavi, Helia, et al.
Publicado: (2020) -
The Role of Interleukin-6 Inhibitors in the Treatment of COVID-19 Infections: A Case Series
por: Tadepalli, Satish, et al.
Publicado: (2020)